These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2482515)

  • 1. Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity binding.
    Feenstra A; Coggiano MA; Wyatt RJ
    Psychiatry Res; 1989 Dec; 30(3):259-64. PubMed ID: 2482515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodology of 3H-spiperone binding to lymphocytes.
    Bondy B; Ackenheil M; Engel RR
    J Psychiatr Res; 1990; 24(1):83-92. PubMed ID: 1694898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dopamine receptors present on human lymphocytes?
    Fleminger S; Jenner P; Marsden CD
    J Pharm Pharmacol; 1982 Oct; 34(10):658-63. PubMed ID: 6128389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sequestration of [3H]spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker?
    Griffiths RS; Chung-a-on KO; Griffiths KD; Payne JW; Davies JI
    J Psychiatr Res; 1992 Jan; 26(1):77-84. PubMed ID: 1560411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic activity of four analogs of butaclamol.
    Collu R; Bouvier C; Basak A; Dugas H
    Pharmacol Res Commun; 1985 Dec; 17(12):1153-7. PubMed ID: 2419927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE; Gommeren W
    J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of 3H-spiperone to peripheral blood cells: relevance for the interpretation of binding studies in psychiatric disorders.
    Henning U; Krieger K; Klimke A
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb; 23(2):225-41. PubMed ID: 10368866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects.
    Wodarz N; Fritze J; Kornhuber J; Riederer P
    Biol Psychiatry; 1992 Feb; 31(3):291-303. PubMed ID: 1532133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--III. The effects of lesions in the parafascicular-intralaminar nuclei on D2 dopamine receptors and high affinity dopamine uptake.
    Kilpatrick IC; Jones MW; Pycock CJ; Riches I; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):991-1005. PubMed ID: 2948134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trapping of labelled ligands in intact cells: a pitfall in binding studies.
    Maloteaux JM; Gossuin A; Waterkeyn C; Laduron PM
    Biochem Pharmacol; 1983 Sep; 32(17):2543-8. PubMed ID: 6615549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
    Kokay IC; Mercer AR
    Brain Res; 1996 Jan; 706(1):47-56. PubMed ID: 8720491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
    Weller ME; Rose S; Jenner P; Marsden CD
    Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex.
    Mita T; Kuno T; Nakai H; Tanaka C
    Jpn J Pharmacol; 1982 Dec; 32(6):1027-32. PubMed ID: 7161958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain.
    Gundlach AL; McDonald D; Beart PM
    J Neurochem; 1982 Sep; 39(3):890-4. PubMed ID: 7097294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.